Figure 14.
In vivo proof of principle of the efficacy of LiPlasomes loaded with cisplatin applied to a human xenograft MT-3 breast cancer in mice. Data from LiPlasome Pharma A/S.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.